FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/10/096619 [Registered on: 29/10/2025] Trial Registered Prospectively
Last Modified On: 29/10/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Homeopathy 
Study Design  Randomized, Parallel Group, Placebo Controlled Trial 
Public Title of Study   EVALUATE THE ROLE OF HOMOEOPATHIC MEDICINE IN CASES OF GOUT 
Scientific Title of Study   An Interventional Study to Evaluate The role of Individualized Homoeopathic Medcine In Cases of Gout 
Trial Acronym  NILL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  OM PRAKASH 
Designation  PG Scholar 
Affiliation  Sri Ganganagar Homoeopathic Medical College Hospital and Research institute 
Address  Dept. of Practice of Medicine Ground floor PG Block Near RIICO Bus Stand Hanumangarh Road Ganganagar Rajasthan

Ganganagar
RAJASTHAN
335002
India 
Phone  8696836019  
Fax    
Email  omprakashparmar017@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Anil Aggarwal 
Designation  HOD and Professor Dept. of Practice of Medicine 
Affiliation  Sri Ganganagar Homoeopathic Medical College Hospital and Research institute 
Address  Dept. of Practice of Medicine Ground floor PG Block Near RIICO Bus Stand Hanumangarh Road Ganganagar Rajasthan

Ganganagar
RAJASTHAN
335002
India 
Phone  9929319610  
Fax    
Email  aggarwal.anil1@gmail.com  
 
Details of Contact Person
Public Query
 
Name  OM PRAKASH 
Designation  PG Scholar 
Affiliation  Sri Ganganagar Homoeopathic Medical College Hospital and Research institute 
Address  Dept. of Practice of Medicine Ground floor PG Block Near RIICO Bus Stand Hanumangarh Road Ganganagar Rajasthan

Ganganagar
RAJASTHAN
335002
India 
Phone  8696836019  
Fax    
Email  omprakashparmar017@gmail.com  
 
Source of Monetary or Material Support  
Sri Ganganagar Homoeopathic medical college, hospital and Research institute, Near RIICO Bus stand, Hanumangarh Road, Sri Ganganagar, Rajasthan 335002 
 
Primary Sponsor  
Name  Sri Ganganagar Homoeopathic medical college hospital and Research centre 
Address  Near RIICO Bus stand Hanumangarh Road Sri Ganganagar Rajasthan 335002 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Om Prakash  Sri Ganganagar Homoeopathic medical college hospital and Research institute  Sri Ganganagar Homoeopathic medical college hospital and Research institute Near RIICO Bus stand Hanumangarh Road Sri Ganganagar Rajasthan 335002
Ganganagar
RAJASTHAN 
8696836019

omprakashparmar017@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional ethics committee Sri Ganganagar Homoeopathic Medical College hospital and Research Institute  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: M109||Gout, unspecified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Homoeopathy   Individualized Homoeopathic Drugs 
Comparator Agent  Not applicable   Not applicable  
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  45.00 Year(s)
Gender  Both 
Details  The patient between the age 18 to 45yr.
The patient diagnosed with high Uric acid level and nephrolithiasis secondary to hyperuracaemia.
The patient giving consent and willing to participate in the study and maintaining follow up  
 
ExclusionCriteria 
Details  Patient with other severe systemic illness of gout.
patient on other analgesic medicine or Co morbidity. 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
1.Reduce pain and redness
2.comparative effectiveness to identify statistical significance between two groups
 
1.Reduce pain and redness within 8 weeks
2.comparative effectiveness to identify statistical significance between two groups after 8 weeks
 
 
Secondary Outcome  
Outcome  TimePoints 
NIL  NIL 
 
Target Sample Size   Total Sample Size="80"
Sample Size from India="80" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   15/11/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  
INTRODUCTION: Intra-articular sodium urate crystals and hyperuricaemia accompany gout, a type of inflammatory arthritis. Red, sore, swollen joints occur frequently in gout attacks. In addition to plasma urate levels higher than 6.0 mg/dl, the presence of monosodium urate monohydrate crystals in the afflicted area is crucial for diagnosis. Menopausal women and middle-aged men have excruciating pain, swelling, and redness in the first MTP joint when they first get acute gout. Alcohol, overindulgence in food, dehydration, and diuretic medication are the usual causes of this acute. People who have persistently elevated levels of uric acid may also have chronic tophaceous gout, and sodium urate can cause tophi, or smooth white deposits, in the skin and surrounding joints. One to four percent of the general population suffers with gout. In Western nations, it affects 3-6% of men and 1% of women. A gout patient’s mind becomes more irritable due to constant discomfort, which has an indirect impact on his personal and professional lives. Their general health and quality of life are greatly impacted by their inability to sleep soundly and their difficulty walking. The optimum time to take precautions is before the sickness manifests. Medication and physical therapy assist the patient in overcoming gout once it has been proven. Gout risk can be reduced by leading a lifestyle that includes nutritious food, frequent exercise, and joint mobility. However, Homeopathy operates in a different way. It is an individualisation science in which every individual is seen as unique and all symptoms-physical. emotional, and mental-were included in a case study. (1)

AIM

To ascertain the role of Individualized Homeopathic medicine in cases of gout.

OBJECTIVES

1. To assess the effectiveness of individualized Homeopathic medicine by comparing pre and post score of NUMERICAL RATING SCALE

2. To evaluate changes in serum uric acid level, following treatment with individualized homoeopathic medicine.
 
Close